GrandOmics Biosciences
Wuhan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A genomics company applying AI and sequencing to reproductive and cancer diagnostics.
Genetics & GenomicsDiagnostics
Technology Platform
Integrated NGS and AI-powered bioinformatics platform for the analysis of genomic data to deliver clinical diagnostic tests and software solutions.
Opportunities
Growth opportunity lies in expanding its oncology diagnostics portfolio and leveraging its data/AI capabilities for drug discovery partnerships.
Risk Factors
Faces risks from regulatory changes in the genetic testing industry, reimbursement challenges, and potential pricing erosion in core service lines.
Competitive Landscape
Operates in the highly competitive and regulated NIPT and clinical sequencing market in China, competing with BGI and numerous other diagnostics companies.